A detailed history of Vermillion & White Wealth Management Group, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Vermillion & White Wealth Management Group, LLC holds 450 shares of PGEN stock, worth $355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
450
Previous 450 -0.0%
Holding current value
$355
Previous $711,000 40.08%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.21 - $1.75 $544 - $787
-450 Reduced 50.0%
450 $653,000
Q4 2023

Feb 13, 2024

BUY
$0.89 - $1.41 $801 - $1,269
900 New
900 $1.21 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $164M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Vermillion & White Wealth Management Group, LLC Portfolio

Follow Vermillion & White Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vermillion & White Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vermillion & White Wealth Management Group, LLC with notifications on news.